BHST · NASDAQ
BioHarvest Sciences (BHST) Stock Price & Fundamentals
BioHarvest Sciences (BHST) closed at $440.03 on Oct 9, 2026, down 0.50% from the previous close of $442.25.
Share price, past year
1Y −1.91%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $440.03 |
| Sep 30, 2026 | $446.77 |
| Aug 31, 2026 | $432.82 |
| Jul 31, 2026 | $408.16 |
| Jun 30, 2026 | $391.59 |
| May 29, 2026 | $419.80 |
| Apr 30, 2026 | $435.43 |
| Mar 31, 2026 | $447.31 |
| Feb 27, 2026 | $442.08 |
| Jan 30, 2026 | $437.76 |
| Dec 31, 2025 | $442.27 |
| Nov 28, 2025 | $436.42 |
| Oct 31, 2025 | $440.24 |
Key statistics
- Market cap
- $9.97B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 22.7M
- Dividend yield
- —
- 52-week range
- $383.70 – $459.78
BioHarvest Sciences's market cap is $9.97B, based on a share price of $440.03 and 22.7M shares outstanding as of Dec 31, 2025.
Financials
BioHarvest Sciences reported revenue of $34.51M for fiscal 2025, up 37.00% from fiscal 2024.
BioHarvest Sciences reported a net loss of $11.14M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $34.51M | +37.0% | −$11.14M | −32.3% | — | −$9.58M |
| FY2024ended Dec 31, 2024 | $25.19M | +98.8% | −$12.91M | −51.3% | — | −$9.52M |
| FY2023ended Dec 31, 2023 | $12.67M | — | −$12.56M | −99.2% | — | −$10.00M |
Company profile
- Name
- BioHarvest Sciences Inc.
- Ticker
- BHST
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 1140 - 625 Howe Street, Vancouver, A1 V6C 2T6
- Incorporated in
- A1
- Fiscal year ends
- December
- SEC CIK
- 0001723464
Frequently asked questions
What is BioHarvest Sciences's stock price?
BioHarvest Sciences (BHST) closed at $440.03 on Oct 9, 2026, down 0.50% from the previous close of $442.25.
What is BioHarvest Sciences's market cap?
BioHarvest Sciences's market cap is $9.97B, based on a share price of $440.03 and 22.7M shares outstanding as of Dec 31, 2025.
How much revenue does BioHarvest Sciences make?
BioHarvest Sciences reported revenue of $34.51M for fiscal 2025, up 37.00% from fiscal 2024.
Sources and methodology
Fundamentals come from BioHarvest Sciences Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures